These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15350936)

  • 1. The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer.
    Garofalo MC; Kwok Y; Regine WF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):589-604, viii. PubMed ID: 15350936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy following resection for pancreatic adenocarcinoma.
    Brennan MF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
    Abrams RA; Yeo CJ
    Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Virginia Mason approach to localized pancreatic cancer.
    Picozzi VJ; Traverso LW
    Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 17. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for adjuvant chemoradiation for pancreatic cancer.
    Garofalo M; Flannery T; Regine W
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):403-16. PubMed ID: 16549335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.